<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/379d–1" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/379d–1/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/379d–1/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_379d_1"><akn:num>379d–1</akn:num><akn:heading>Conflicts of interest</akn:heading><akn:content><akn:p>§ 379d–1. Conflicts of interest(a) DefinitionsFor purposes of this section:(1) Advisory committeeThe term “advisory committee” means an advisory committee under chapter 10 of title 5 that provides advice or recommendations to the Secretary regarding activities of the Food and Drug Administration.


(2) Financial interestThe term “financial interest” means a financial interest under section 208(a) of title 18.



(b) Recruitment for advisory committees(1) In generalThe Secretary shall—(A) develop and implement strategies on effective outreach to potential members of advisory committees at universities, colleges, other academic research centers, professional and medical societies, and patient and consumer groups;

(B) seek input from professional medical and scientific societies to determine the most effective informational and recruitment activities;

(C) at least every 180 days, request referrals for potential members of advisory committees from a variety of stakeholders, including—(i) product developers, patient groups, and disease advocacy organizations; and

(ii) relevant—(I) professional societies;

(II) medical societies;

(III) academic organizations; and

(IV) governmental organizations; and



(D) in carrying out subparagraphs (A) and (B), take into account the levels of activity (including the numbers of annual meetings) and the numbers of vacancies of the advisory committees.


(2) Recruitment activitiesThe recruitment activities under paragraph (1) may include—(A) advertising the process for becoming an advisory committee member at medical and scientific society conferences;

(B) making widely available, including by using existing electronic communications channels, the contact information for the Food and Drug Administration point of contact regarding advisory committee nominations; and

(C) developing a method through which an entity receiving funding from the National Institutes of Health, the Agency for Healthcare Research and Quality, the Centers fo</akn:p></akn:content><akn:subsection eId="subsec_379d_1_a"><akn:num>(a)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(a) Definitions For purposes of this section:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379d_1_b"><akn:num>(b)</akn:num><akn:heading>Recruitment for advisory committees</akn:heading><akn:content><akn:p>(b) Recruitment for advisory committees</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379d_1_c"><akn:num>(c)</akn:num><akn:heading>Disclosure of determinations and certifications</akn:heading><akn:content><akn:p>(c) Disclosure of determinations and certifications Notwithstanding section 13109(a)(2) of title 5, the following shall apply:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379d_1_d"><akn:num>(d)</akn:num><akn:heading>Public record</akn:heading><akn:content><akn:p>(d) Public record The Secretary shall ensure that the public record and transcript of each meeting of an advisory committee includes the disclosure required under subsection (c) (other than information exempted from disclosure under section 552 of title 5 and section 552a of title 5).</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379d_1_e"><akn:num>(e)</akn:num><akn:heading>Annual report</akn:heading><akn:content><akn:p>(e) Annual report</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379d_1_f"><akn:num>(f)</akn:num><akn:heading>Periodic review of guidance</akn:heading><akn:content><akn:p>(f) Periodic review of guidance Not less than once every 5 years, the Secretary shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379d_1_g"><akn:num>(g)</akn:num><akn:heading>Guidance on reported disclosed financial interest or involvement</akn:heading><akn:content><akn:p>(g) Guidance on reported disclosed financial interest or involvement The Secretary shall issue guidance that describes how the Secretary reviews the financial interests and involvement of advisory committee members that are disclosed under subsection (c) but that the Secretary determines not to meet the definition of a disqualifying interest under section 208 of title 18 for the purposes of participating in a particular matter.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>